Skip to content
Clinical Trials – home
FinlandBack to Finland

Clinical trials in Kokkola

26 clinical trials in Kokkola, Finland across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

FinlandOur site in FinlandKliinisetTutkimukset.fi(opens in a new tab)
Kokkola at a glance
26
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

26 trials in Kokkola

Open in trial search

Phase 2b Study of VXB-221 and VXB-213 Protein Vaccine for Prevention of Respiratory Syncytial Virus and Human Metapneumovirus Infections in Adults ≥60 Years

Investigational
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:VXB-213
  • Sponsor:Sanofi Pasteur Inc.

Study on Selatogrel for Preventing Heart Attack in Patients with Recent Heart Attack History

Investigational
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Selatogrel
  • Sponsor:Viatris Innovation GmbH

Safety and immune response of PF-07872412 compared with 20-valent pneumococcal conjugate vaccine for pneumococcal disease in healthy children and adolescents

Registered drugNo placebo
Countries:FinlandFinland
  • Participants:0–17 years
  • Substances:PF-07831695
  • Sponsor:Pfizer Inc.

Influenza+1

Recruiting

Efficacy and safety of the investigational mRNA influenza vaccine gskvx000000077430 (drug combination) in adults ≥ 65 years

Registered drugNo placebo
Countries:FinlandFinland
  • Participants:65+ years · Healthy volunteers
  • Substances:GSKVX000000077430
  • Sponsor:GlaxoSmithKline Biologicals

Safety of PF-07872412 versus 20‑valent pneumococcal conjugate vaccine in healthy infants for prevention of pneumococcal disease

Registered drugNo placebo
Countries:FinlandFinland
  • Participants:0–17 years
  • Substances:PF-07831695
  • Sponsor:Pfizer Inc.

A Study of Group B Streptococcus 6-Valent Polysaccharide Conjugate Vaccine in Healthy Pregnant Women and Their Infants

Investigational
Countries:FinlandFinland
  • Participants:0–17 years · 18–64 years · Healthy volunteers
  • Substances:GROUP B STREPTOCOCCUS CAPSULAR POLYSACCHARIDE IB CONJUGATED TO DIPHTHERIA TOXIN CRM197
  • Sponsor:Pfizer Inc.

Study on the Effects of Fluorouracil and Capecitabine in Patients with Metastatic Colorectal Cancer

Registered drugNo placebo
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:HUS-yhtymae

Wheezing+1

Recruiting

Study on Oral Prednisolone and Sucrose for Treating Wheezing Caused by Rhinovirus in Children Under 2 Years Old

Registered drug
Countries:FinlandFinland
  • Participants:0–17 years
  • Substances:Sucrose
  • Sponsor:University Of Oulu

Metapneumovirus infection

Not yet recruiting

Study on the Effectiveness and Safety of IVX-A12 Vaccine for Preventing Respiratory Infections in Adults Aged 60 and Older

Investigational
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:IVX-121
  • Sponsor:AstraZeneca AB
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:GSKVx000000017064
  • Sponsor:GlaxoSmithKline Biologicals

Lyme disease

Not recruiting

Study on the Effectiveness and Safety of the VLA15 Vaccine for Preventing Lyme Disease in Healthy Individuals Aged 5 and Older

Registered drug
Countries:FinlandFinland
  • Participants:0–17 years · 18–64 years · 65+ years · Healthy volunteers
  • Substances:Lip-D1B2B
  • Sponsor:Pfizer Inc.

Study on the Safety and Immune Response of a Booster Dose of MenACYW Conjugate Vaccine in Children and Adolescents Previously Vaccinated for Meningococcal Infection

Registered drugNo placebo
Countries:FinlandFinland
  • Participants:0–17 years · Healthy volunteers
  • Substances:Tetanus toxoid
  • Sponsor:Sanofi Winthrop Industrie

Other cities in Finland

The busiest research cities in the country

All 28 cities in Finland

Clinical research in Kokkola

What the registry says about research in the country

01 Respiratory Viral Infections

Extensive research focusing on respiratory syncytial virus (RSV) and influenza prevention through innovative vaccine development. Studies aim to protect both vulnerable populations and healthy adults.

  • RSV vaccines for older adults and infants
  • Influenza vaccine efficacy studies
  • Human Metapneumovirus prevention

Multiple clinical trials evaluating both preventive measures and therapeutic interventions for respiratory infections.

02 Bacterial Infections

Significant developments in preventing meningococcal and pneumococcal infections through advanced vaccine research, particularly focusing on pediatric populations.

  • Meningococcal conjugate vaccines
  • Pneumococcal vaccine studies
  • Long-term immunity evaluation

Research emphasizes vaccine safety and immunogenicity in different age groups.

03 Viral Disease Prevention

Comprehensive studies on Herpes Zoster and Cytomegalovirus prevention, exploring novel vaccine technologies including mRNA platforms.

  • CMV infection prevention
  • Herpes Zoster vaccine efficacy
  • Rhinovirus treatment studies

Focus on developing long-lasting immunity and reducing disease burden in susceptible populations.

04 Cardiovascular Research

Innovative research investigating emergency interventions for acute myocardial infarction, including self-administered treatments.

  • AMI emergency treatment
  • Preventive interventions
  • Patient self-management

Studies aim to improve outcomes in high-risk cardiac patients through rapid intervention strategies.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.